Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA GENITAL WARTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 DISTRIBUTION CHANNEL LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
5 EPIDEMIOLOGY
6 PORTER'S FIVE FORCES MODEL
7 PESTEL ANALYSIS
8 PIPELINE ANALYSIS: MIDDLE EAST AND AFRICA GENITAL WARTS MARKET
9 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: REGULATIONS
9.1 CANADA
9.2 U.S.
9.3 EUROPE
9.4 JAPAN
9.5 MALAYSIA
9.6 VIETNAM
9.7 SOUTH AMERICA
10 MARKET OVERVIEW
10.1 DRIVERS
10.1.1 RISE IN PREVALENCE OF SEXUALLY TRANSMITTED DISEASES AND HUMAN PAPILLOMAVIRUS (HPV) VIRUS
10.1.2 RISE OF MALE POPULATION
10.1.3 RISE IN GOVERNMENT INITIATIVES AND AWARENESS PROGRAMMES
10.1.4 RISE IN CLINICAL TRIALS
10.1.5 RISE IN HEALTHCARE EXPENDITURE
10.2 RESTRAINTS
10.2.1 RISE IN COST FOR GENITAL WARTS TREATMENT
10.2.2 SIDE EFFECTS OBSERVED WHILE UNDERGOING THE TREATMENT FOR GENITAL WARTS
10.2.3 LACK OF PATIENT AND CONSUMER AWARENESS
10.2.4 LESS DIAGNOSTIC RATE
10.3 OPPORTUNITIES
10.3.1 USE OF LASER TREATMENT AND CRYOTHERAPY FOR TREATMENT OF GENITAL WARTS.
10.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS.
10.3.3 RESEARCH AND DEVELOPMENT FOR GENERIC MEDICATIONS
10.4 CHALLENGES
10.4.1 RISE IN PRODUCT RECALL.
10.4.2 PATIENT COMPLIANCE REGARDING THE USE OF VACCINES AND OINTMENTS FOR TREATMENT OF GENITAL WARTS
11 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA GENITAL WARTS MARKET
11.1 IMPACT ON PRICE
11.2 IMPACT ON DEMAND
11.3 IMPACT ON SUPPLY CHAIN
11.4 STRATEGIC DECISIONS BY MANUFACTURERS
11.5 CONCLUSION
12 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY MORPHOLOGY
12.1 OVERVIEW
12.2 CAULIFLOWER-LIKE
12.3 SMOOTH PAPULAR
12.4 KERATOTIC
12.5 FLAT WARTS
13 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY TYPE
13.1 OVERVIEW
13.2 PREVENTION
13.3 DIAGNOSTIC
13.3.1 HPV TEST
13.3.2 PAP TEST
13.4 TREATMENT
13.4.1 PHARMACOLOGICAL TREATMENT
13.4.1.1 Imiquimod
13.4.1.2 Podophyllin and Podofilox
13.4.1.3 Trichloroacetic Acid
13.4.1.4 Sinecatechins
13.4.1.5 others
13.4.2 NON- PHARMACOLOGICAL TREATMENT
13.4.2.1 Cryotherapy
13.4.2.2 Electrocautery
13.4.2.3 Laser Treatment
13.4.2.4 Surgical Excision
13.4.3 GARDASIL
13.4.4 CERVARIX
14 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY CAUSE
14.1 OVERVIEW
14.2 HPV 6
14.3 HPV 11
14.4 OTHERS
15 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY LOCATION
15.1 OVERVIEW
15.2 VULVA
15.3 CERVIX UTERI
15.4 URETHRA
15.5 ANUS
15.6 SCROTUM
16 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY GENDER
16.1 OVERVIEW
16.2 FEMALE
16.3 MALE
17 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY DOSAGE
17.1 OVERVIEW
17.2 CREAM
17.3 GEL
17.4 OINTMENT
17.5 INTRAMUSCULARLY
17.6 OTHERS
18 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY END USER
18.1 OVERVIEW
18.2 HOSPITALS
18.3 DIAGNOSTIC CENTERS
18.4 SURGICAL CENTERS
18.5 AMBULATORY SURGICAL CENTERS
18.6 OTHERS
19 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL
19.1 OVERVIEW
19.2 DIRECT TENDER
19.3 PHARMACY STORES
19.4 OTHERS
20 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY REGION
20.1 MIDDLE EAST AND AFRICA
20.1.1 SOUTH AFRICA
20.1.2 SAUDI ARABIA
20.1.3 U.A.E.
20.1.4 EGYPT
20.1.5 KUWAIT
20.1.6 ISRAEL
20.1.7 REST OF MIDDLE EAST AND AFRICA
21 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
22 SWOT ANALYSIS
23 COMPANY PROFILE
23.1 MERCK SHARP & DOHME CORP., A SUBSIDIARY OF MERCK & CO., INC.
23.1.1 COMPANY SNAPSHOT
23.1.2 REVENUE ANALYSIS
23.1.3 COMPANY SHARE ANALYSIS
23.1.4 PRODUCT PORTFOLIO
23.1.5 RECENT DEVELOPMENT
23.2 GLAXOSMITHKLINE PLC
23.2.1 COMPANY SNAPSHOT
23.2.2 REVENUE ANALYSIS
23.2.3 COMPANY SHARE ANALYSIS
23.2.4 PRODUCT PORTFOLIO
23.2.5 RECENT DEVELOPMENTS
23.3 BAUSCH HEALTH COMPANIES INC.
23.3.1 COMPANY SNAPSHOT
23.3.2 REVENUE ANALYSIS
23.3.3 COMPANY SHARE ANALYSIS
23.3.4 PRODUCT PORTFOLIO
23.3.5 RECENT DEVELOPMENTS
23.4 ANI PHARMACEUTICALS, INC.
23.4.1 COMPANY SNAPSHOT
23.4.2 REVENUE ANALYSIS
23.4.3 COMPANY SHARE ANALYSIS
23.4.4 PRODUCT PORTFOLIO
23.4.5 RECENT DEVELOPMENTS
23.5 BIONTECH SE
23.5.1 COMPANY SNAPSHOT
23.5.2 REVENUE ANALYSIS
23.5.3 COMPANY SHARE ANALYSIS
23.5.4 PRODUCT PORTFOLIO
23.5.5 RECENT DEVELOPMENTS
23.6 CASSIOPEA, INC.
23.6.1 COMPANY SNAPSHOT
23.6.2 PRODUCT PORTFOLIO
23.6.3 RECENT DEVELOPMENTS
23.7 CRYOCONCEPTS LP
23.7.1 COMPANY SNAPSHOT
23.7.2 PRODUCT PORTFOLIO
23.7.3 RECENT DEVELOPMENT
23.8 CRYOIQ
23.8.1 COMPANY SNAPSHOT
23.8.2 PRODUCT PORTFOLIO
23.8.3 RECENT DEVELOPMENT
23.9 CRYOSURGERY, INC.
23.9.1 COMPANY SNAPSHOT
23.9.2 PRODUCT PORTFOLIO
23.9.3 RECENT DEVELOPMENT
23.1 EDGE PHARMA
23.10.1 COMPANY SNAPSHOT
23.10.2 PRODUCT PORTFOLIO
23.10.3 RECENT DEVELOPMENT
23.11 FOTONA
23.11.1 COMPANY SNAPSHOT
23.11.2 PRODUCT PORTFOLIO
23.11.3 RECENT DEVELOPMENTS
23.12 GLENMARK PHARMACEUTICAL INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICALS LTD.)
23.12.1 COMPANY SNAPSHOT
23.12.2 REVENUE ANALYSIS
23.12.3 PRODUCT PORTFOLIO
23.12.4 RECENT DEVELOPMENT
23.13 NOVAN, INC.
23.13.1 COMPANY SNAPSHOT
23.13.2 REVENUE ANALYSIS
23.13.3 PRODUCT PORTFOLIO
23.13.4 RECENT DEVELOPMENTS
23.14 ORGENESIS INC.
23.14.1 COMPANY SNAPSHOT
23.14.2 REVENUE ANALYSIS
23.14.3 PRODUCT PORTFOLIO
23.14.4 RECENT DEVELOPMENT
23.15 PERRIGO COMPANY PLC
23.15.1 COMPANY SNAPSHOT
23.15.2 REVENUE ANALYSIS
23.15.3 PRODUCT PORTFOLIO
23.15.4 RECENT DEVELOPMENT
23.16 SERUM INSTITUTE OF INDIA PVT. LTD.
23.16.1 COMPANY SNAPSHOT
23.16.2 PRODUCT PORTFOLIO
23.16.3 RECENT DEVELOPMENT
23.17 TARO PHARMACEUTICAL INDUSTRIES LTD.
23.17.1 COMPANY SNAPSHOT
23.17.2 REVENUE ANALYSIS
23.17.3 PRODUCT PORTFOLIO
23.17.4 RECENT DEVELOPMENT
23.18 VERRICA PHARMACEUTICALS
23.18.1 COMPANY SNAPSHOT
23.18.2 REVENUE ANALYSIS
23.18.3 PRODUCT PORTFOLIO
23.18.4 RECENT DEVELOPMENTS
24 QUESTIONNAIRE
25 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, PIPELINE ANALYSIS
TABLE 2 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA CAULIFLOWER-LIKE IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA SMOOTH PAPULAR IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA KERATOTIC IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA FLAT WARTS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA PREVENTION IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DIAGNOSTIC IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA TREATMENT IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA NON- PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA HPV 6 IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA HPV 11 IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA VULVA IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA CERVIX UTERI IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA URETHRA IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA ANUS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA SCROTUM IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA FEMALE IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA MALE IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA CREAM IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA GEL IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA OINTMENT IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA INTRAMUSCULARLY IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA HOSPITALS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA DIAGNOSTIC CENTERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA SURGICAL CENTERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA DIRECT TENDER IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA PHARMACY STORES IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA GENITAL WARTS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA GARDASIL GENITAL WARTS MARKET, BY TYPE, 2019-2028, (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA CERVARIX GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 SOUTH AFRICA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 62 SOUTH AFRICA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 63 SOUTH AFRICA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 SOUTH AFRICA DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 SOUTH AFRICA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 66 SOUTH AFRICA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 67 SOUTH AFRICA NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 SOUTH AFRICA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 69 SOUTH AFRICA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 70 SOUTH AFRICA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 71 SOUTH AFRICA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 72 SOUTH AFRICA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 SOUTH AFRICA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 74 SAUDI ARABIA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 75 SAUDI ARABIA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 SAUDI ARABIA GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)
TABLE 77 SAUDI ARABIA DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 SAUDI ARABIA TYPE IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 SAUDI ARABIA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 SAUDI ARABIA NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 SAUDI ARABIA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 82 SAUDI ARABIA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 83 SAUDI ARABIA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 84 SAUDI ARABIA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 85 SAUDI ARABIA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 SAUDI ARABIA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 U.A.E. GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 88 U.A.E. GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 U.A.E. GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)
TABLE 90 U.A.E. DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 U.A.E. TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 U.A.E. PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 93 U.A.E. NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 U.A.E. GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 95 U.A.E. GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 96 U.A.E. GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 97 U.A.E. GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 98 U.A.E. GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 U.A.E. GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 100 EGYPT GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 101 EGYPT GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 102 EGYPT GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)
TABLE 103 EGYPT DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 EGYPT TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 EGYPT PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 EGYPT NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 EGYPT GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 108 EGYPT GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 109 EGYPT GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 110 EGYPT GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 111 EGYPT GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 112 EGYPT GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 113 KUWAIT GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 114 KUWAIT GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 115 KUWAIT GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)
TABLE 116 KUWAIT DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 117 KUWAIT TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 KUWAIT PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 KUWAIT NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 KUWAIT GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 121 KUWAIT GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 122 KUWAIT GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 123 KUWAIT GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 124 KUWAIT GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 125 KUWAIT GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 126 ISRAEL GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
TABLE 127 ISRAEL GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 ISRAEL GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)
TABLE 129 ISRAEL DIAGNOSIS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 130 ISRAEL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 131 ISRAEL PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 132 ISRAEL NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 133 ISRAEL GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)
TABLE 134 ISRAEL GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)
TABLE 135 ISRAEL GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 136 ISRAEL GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)
TABLE 137 ISRAEL GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 138 ISRAEL GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 139 REST OF MIDDLE EAST AND AFRICA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: SEGMENTATION
FIGURE 11 RISE OF MALE POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA GENITAL WARTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CAULIFLOWER-LIKE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA GENITAL WARTS MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA GENITAL WARTS MARKET
FIGURE 14 PREVALENCE OF SEXUALLY TRANSMITTED DISEASES IN THE U.S., AUSTRALIA AND CANADA
FIGURE 15 INFECTION RATE OF SEXUALLY TRANSMITTED DISEASES (STDS) IN THE FOLLOWING COUNTRIES
FIGURE 16 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY MORPHOLOGY, 2020
FIGURE 17 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY MORPHOLOGY, 2021-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY MORPHOLOGY, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY MORPHOLOGY, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY TYPE, 2020
FIGURE 21 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY TYPE, 2021-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY CAUSE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY CAUSE, 2021-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY CAUSE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY CAUSE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY LOCATION 2020
FIGURE 29 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY LOCATION 2021-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY LOCATION CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY LOCATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY GENDER 2020
FIGURE 33 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY GENDER 2021-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY GENDER CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY GENDER, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DOSAGE 2020
FIGURE 37 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DOSAGE 2021-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DOSAGE CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY END USER, 2020
FIGURE 41 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 44 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 45 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 46 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 47 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET : SNAPSHOT (2020)
FIGURE 49 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET : BY COUNTRY (2020)
FIGURE 50 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET : BY COUNTRY (2021 & 2028)
FIGURE 51 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET : BY COUNTRY (2020 & 2028)
FIGURE 52 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET : BY MORPHOLOGY (2021-2028)
FIGURE 53 MIDDLE EAST AND AFRICA GENITAL WARTS MARKET: COMPANY SHARE 2020 (%)
